Andreas M. Kany

591 total citations
33 papers, 325 citations indexed

About

Andreas M. Kany is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Andreas M. Kany has authored 33 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Organic Chemistry and 5 papers in Infectious Diseases. Recurrent topics in Andreas M. Kany's work include Bacterial biofilms and quorum sensing (7 papers), Antimicrobial Peptides and Activities (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Andreas M. Kany is often cited by papers focused on Bacterial biofilms and quorum sensing (7 papers), Antimicrobial Peptides and Activities (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Andreas M. Kany collaborates with scholars based in Germany, Egypt and Austria. Andreas M. Kany's co-authors include Rolf W. Hartmann, Jörg Haupenthal, Anna K. H. Hirsch, Samir Yahiaoui, Martin Empting, Asfandyar Sikandar, Rolf Müller, Christine K. Maurer, Wulf Blankenfeldt and Ewgenij Proschak and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Scientific Reports.

In The Last Decade

Andreas M. Kany

28 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas M. Kany Germany	12	200	96	50	39	35	33	325
Giambattista Testolin Germany	8	153 0.8×	77 0.8×	50 1.0×	88 2.3×	39 1.1×	8	347
Kenneth Rachwalski Canada	7	127 0.6×	81 0.8×	35 0.7×	31 0.8×	45 1.3×	12	331
Stefan Hinsberger Germany	7	250 1.3×	98 1.0×	87 1.7×	63 1.6×	22 0.6×	8	363
Reetika Debroy India	12	178 0.9×	77 0.8×	37 0.7×	23 0.6×	15 0.4×	13	358
Christian Fetzer Germany	9	154 0.8×	44 0.5×	37 0.7×	71 1.8×	13 0.4×	15	285
Markus Lakemeyer Germany	10	255 1.3×	58 0.6×	58 1.2×	104 2.7×	60 1.7×	16	447
Logan D. Andrews United States	10	190 0.9×	83 0.9×	18 0.4×	35 0.9×	16 0.5×	11	331
Kelvin J. Y. Wu United States	7	150 0.8×	51 0.5×	28 0.6×	63 1.6×	29 0.8×	13	301
Jordi Zamarreño Beas Portugal	6	156 0.8×	122 1.3×	49 1.0×	38 1.0×	48 1.4×	9	365
Kirsten J. Meyer United States	9	143 0.7×	42 0.4×	42 0.8×	32 0.8×	8 0.2×	15	271

Countries citing papers authored by Andreas M. Kany

Since Specialization

Citations

This map shows the geographic impact of Andreas M. Kany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas M. Kany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas M. Kany more than expected).

Fields of papers citing papers by Andreas M. Kany

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas M. Kany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas M. Kany. The network helps show where Andreas M. Kany may publish in the future.

Co-authorship network of co-authors of Andreas M. Kany

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas M. Kany. A scholar is included among the top collaborators of Andreas M. Kany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas M. Kany. Andreas M. Kany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Stein, Saskia C., Andreas M. Kany, Brigitta Loretz, et al.. (2025). Toward Anti‐Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma‐Associated Herpesvirus Latency‐Associated Nuclear Antigen. ChemMedChem. 21(1). e202500758–e202500758.

2.

Kany, Andreas M., Karin Bartel, Norbert Reiling, et al.. (2025). Design, Synthesis, and Biological Evaluation of Mono- and Diamino-Substituted Squaramide Derivatives as Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthase. Journal of Medicinal Chemistry. 68(23). 25274–25289.

3.

Zimmerman, Matthew, Curtis A. Engelhart, Patrick K. Quoika, et al.. (2025). Tailored phenyl ureas eradicate drug-resistant Mycobacterium tuberculosis by targeting mycolic acid cell wall assembly. Chemical Science. 16(21). 9472–9483.

4.

Kany, Andreas M., Alireza Abadi, Anna K. H. Hirsch, et al.. (2025). From Dyrk1A inhibitors to a novel class of antiviral agents: Targeting Enterovirus EV-A71 with 2-aryl-substituted thiophene scaffolds. European Journal of Medicinal Chemistry. 287. 117348–117348.

5.

Illarionov, Boris, Katharina Rox, Markus Fischer, et al.. (2024). Targeting Plasmodium falciparum IspD in the Methyl- d -erythritol Phosphate Pathway: Urea-Based Compounds with Nanomolar Potency on Target and Low-Micromolar Whole-Cell Activity. Journal of Medicinal Chemistry. 67(19). 17070–17086. 4 indexed citations

6.

Haupenthal, Jörg, Andreas M. Kany, Eleonora Diamanti, et al.. (2024). Target-Directed Dynamic Combinatorial Chemistry Affords Binders of Mycobacterium tuberculosis IspE. ACS Omega. 9(36). 38160–38168. 2 indexed citations

7.

Hoff, Katharina J., Yunqi Li, Jörg Haupenthal, et al.. (2024). Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity. Journal of Medicinal Chemistry. 67(19). 17363–17391. 2 indexed citations

8.

Junca, Howard, Andreas M. Kany, Lena J. Daumann, et al.. (2024). Isocyanides inhibit bacterial pathogens by covalent targeting of essential metabolic enzymes. Chemical Science. 15(30). 11946–11955. 5 indexed citations

9.

Gabr, Moustafa T., Leonardo Pisani, Daniela Valeria Miniero, et al.. (2024). Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity. European Journal of Medicinal Chemistry. 269. 116266–116266. 10 indexed citations

10.

Carvalho, Laís Pessanha de, Bernd Morgenstern, Andreas M. Kany, et al.. (2024). Functionalization of Chlorotonils: Dehalogenil as Promising Lead Compound for In Vivo Application. Angewandte Chemie International Edition. 63(19). e202319765–e202319765. 1 indexed citations

11.

Abdelsamie, Ahmed S., Mostafa M. Hamed, Christian Schütz, et al.. (2024). Discovery and optimization of thiazole-based quorum sensing inhibitors as potent blockers of Pseudomonas aeruginosa pathogenicity. European Journal of Medicinal Chemistry. 276. 116685–116685. 5 indexed citations

12.

Fink‐Straube, Claudia, et al.. (2024). Thermo-amplifier circuit in probiotic E. coli for stringently temperature-controlled release of a novel antibiotic. Journal of Biological Engineering. 18(1). 66–66. 5 indexed citations

13.

Kany, Andreas M., et al.. (2024). Structure Revision of Halisphingosine A via Total Synthesis and Bioactivity Studies. Angewandte Chemie International Edition. 63(52). e202416036–e202416036. 1 indexed citations

14.

Hamed, Mostafa M., Ahmed S. Abdelsamie, Katharina Rox, et al.. (2023). Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof‐of‐Principle. Advanced Science. 10(5). e2204443–e2204443. 18 indexed citations

15.

Afanasenko, Anastasiia M., Alessandra De Santi, Walid A. M. Elgaher, et al.. (2023). Clean Synthetic Strategies to Biologically Active Molecules from Lignin: A Green Path to Drug Discovery**. Angewandte Chemie. 136(4). 8 indexed citations

16.

Afanasenko, Anastasiia M., Alessandra De Santi, Walid A. M. Elgaher, et al.. (2023). Clean Synthetic Strategies to Biologically Active Molecules from Lignin: A Green Path to Drug Discovery**. Angewandte Chemie International Edition. 63(4). e202308131–e202308131. 22 indexed citations

17.

Adam, Sebastian, M Gentilini, Andreas M. Kany, et al.. (2021). Structure‐Activity Relationship and Mode‐Of‐Action Studies Highlight 1‐(4‐Biphenylylmethyl)‐1H‐imidazole‐Derived Small Molecules as Potent CYP121 Inhibitors. ChemMedChem. 16(18). 2786–2801. 9 indexed citations

18.

Schütz, Christian, Mostafa M. Hamed, Ahmed S. Abdelsamie, et al.. (2021). Divergent synthesis and biological evaluation of 2-(trifluoromethyl)pyridines as virulence-attenuating inverse agonists targeting PqsR. European Journal of Medicinal Chemistry. 226. 113797–113797. 11 indexed citations

19.

Murgia, Xabier, Andreas M. Kany, Christian Herr, et al.. (2020). Micro-rheological properties of lung homogenates correlate with infection severity in a mouse model of Pseudomonas aeruginosa lung infection. Scientific Reports. 10(1). 16502–16502. 17 indexed citations

20.

Schönauer, Esther, Andreas M. Kany, Jörg Haupenthal, et al.. (2017). Discovery of a Potent Inhibitor Class with High Selectivity toward Clostridial Collagenases. Journal of the American Chemical Society. 139(36). 12696–12703. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact